Reduced Aqueous Retinol-Binding Protein 3 Concentration Is Associated With Diabetic Macular Edema and Progression of Diabetic Retinopathy
This study suggests that aqueous RBP3 may be an important protective factor, the first neuroretinal-specific biomarker of DME or DR progression, and a possible therapeutic target.
Authors
- Kyoungmin Park (ORCID: https://orcid.org/0000-0003-0772-1217)
- George L. King (ORCID: https://orcid.org/0000-0002-0335-5881)
- Jennifer K. Sun (ORCID: https://orcid.org/0000-0003-0915-6303)
- Hetal Shah (ORCID: https://orcid.org/0000-0002-3685-4572)
- I‐Hsien Wu (ORCID: https://orcid.org/0000-0002-2563-7505)
- Lloyd Paul Aiello (ORCID: https://orcid.org/0000-0003-2012-3465)
- Tanvi Chokshi (ORCID: https://orcid.org/0000-0002-7592-8685)
- Ward Fickweiler
- Surya Jangolla
Institutions
- Joslin Diabetes Center (US)
- Harvard University (US)
Publication Details
- Journal
- Diabetes Care
- Published
- 2024-11-20
- DOI
- https://doi.org/10.2337/dc24-1260
- Citations
- 5
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.69
Funders
- American Diabetes Association
- National Eye Institute
- Division of Diabetes, Endocrinology, and Metabolic Diseases